ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2339

Detecting Inflammation in Vivo Using Activatable Fluorescence Contrast Agents in Inflammatory Arthritis

Monica Guma1, Beatrix Bartok2, Viet Anh Nguyen Huu3, Mathieu L. Viger3, Jacques Lux3, Shivanjali Joshi-Barr3, Adah Almutairi3 and Gary S. Firestein4, 1Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 2Division of Rheumatology, allergy and immunology, University of California, San Diego, La Jolla, CA, 3UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences., University of California, San Diego, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Imaging, Inflammation, inflammatory arthritis and nanomedicine

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

 

Background/Purpose: Current medical imaging technology detects structural rather than functional manifestations of disease.  Imaging agents designed to enhance signal based on molecular mechanisms might permit earlier diagnosis and personalized treatment. We examined whether optical contrast agents whose fluorescence properties may be switched from OFF to ON in response to specific biological stimuli can identify inflammation in vivo in the murine serum transfer-induced arthritis model.

Methods: Mice were injected with 150 ml of K/BxN sera on day 0. At day 5, mice were injected intravenously with an imaging agent and visualized by IVIS® in vivo imaging system. Clinical arthritis scores were assessed. The imaging agent consists of H2O2– and acid-responsive polymeric particles (size: 250 nm) packed with a high concentration of near infrared (NIR) dyes. The close proximity of the dye molecules quenches their fluorescence, thus creating an “off-state“. The signal of this agent is “turned on” through the cleavage of protecting moieties on the polymer backbones upon exposure to either H2O2 or acidic pH, which reveals hydroxyl groups and thus increases the material’s hydrophilicity. After the hydrophobicity switch, dye molecules diffuse out of the polymer matrix, relieving the particle from fluorescence quenching (“on-state”) (Figure 1).

Results: After injecting particles (dose: 100 mL of 0.7 mg/mL Hy-Dex-IR780 in DPBS) intravenously on day 5 after arthritis induction, mice were imaged by IVIS®. Regions of inflammation exhibited significantly higher fluorescence intensity measured as an average of radiant efficiency of paws between non-arthritic and arthritic joints (1.91E+07±1.5E+06 vs 4.44E+07±1.85E+07; p<0.05). This activation results from inflammation-triggered release of dye molecules, as fluorescence was insignificant in healthy animals, and a non-responsive control version poly(lactic-co-glycolic acid)-IR780 was not activated by inflammation. Radiant efficiency in each paw significantly correlated with their clinical score. For example, a paw with a clinical score of 4 had radiant efficiency of 6.95E+07 while a paw with clinical score of 1 had 2.58E+07.

Conclusion: These results suggest that a novel activatable bioimaging agent can detect inflammation in vivo for clinical diagnosis of inflammatory conditions or to assess inflammation in animal models.

Figure 1. Particles composed of H2O2– and acid-responsive polymers partially disassemble upon exposure to either stimulus, activating fluorescence by relieving the particle from self-quenching. Since the NIR dye is not fluorescent in aqueous environments, only the particles light up.

 


Disclosure:

M. Guma,
None;

B. Bartok,
None;

V. A. Nguyen Huu,
None;

M. L. Viger,
None;

J. Lux,
None;

S. Joshi-Barr,
None;

A. Almutairi,
None;

G. S. Firestein,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detecting-inflammation-in-vivo-using-activatable-fluorescence-contrast-agents-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology